Patent details

Basic Information

Publication number:

EP2785717

PCT Application Number:

PCT/IB/2012/056796

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP128057759

PCT Publication Number:

WO/2013/080141

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRAZOLOPYRROLIDINE COMPOUNDS

French Title of Invention:

COMPOSÉS PYRAZOLOPYRROLIDINE

German Title of Invention:

PYRAZOLOPYRROLIDINVERBINDUNGEN

SPC Number:

Dates

Filing date:

28/11/2012

Grant date:

13/01/2016

EP Publication Date:

13/01/2016

PCT Publication Date:

06/06/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/10/2014

EP B1 Publication Date:

13/01/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/11/2016

Expiration date:

28/11/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/11/2012

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

MAH Robert

Address:

Switzerland (CH)

2

Name:

MASUYA Keiichi

Address:

Switzerland (CH)

3

Name:

STUTZ Stefan

Address:

Switzerland (CH)

4

Name:

VAUPEL Andrea

Address:

Switzerland (CH)

5

Name:

SCHLAPBACH Achim

Address:

Switzerland (CH)

6

Name:

GUAGNANO Vito

Address:

Switzerland (CH)

7

Name:

HOLZER Philipp

Address:

Switzerland (CH)

8

Name:

FURET Pascal

Address:

Switzerland (CH)

Priority

Priority Number:

201161564591

Priority Date:

29/11/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 487/04;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages